{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T03:14:34Z","timestamp":1780542874182,"version":"3.54.1"},"update-to":[{"DOI":"10.1002\/14651858.cd001689.pub3","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2021,3,29]],"date-time":"2021-03-29T00:00:00Z","timestamp":1616976000000}}],"reference-count":178,"publisher":"Wiley","issue":"3","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd001689.pub4","type":"journal-article","created":{"date-parts":[[2021,3,29]],"date-time":"2021-03-29T09:14:20Z","timestamp":1617009260000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Venous thromboembolism prophylaxis for women at risk during pregnancy and the early postnatal period"],"prefix":"10.1002","volume":"2021","author":[{"given":"Philippa","family":"Middleton","sequence":"additional","affiliation":[{"name":"Healthy Mothers, Babies and Children, South Australian Health and Medical Research Institute; Adelaide Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Shepherd","sequence":"additional","affiliation":[{"name":"Robinson Research Institute, Discipline of Obstetrics and Gynaecology, Adelaide Medical School; The University of Adelaide; Adelaide Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith C","family":"Gomersall","sequence":"additional","affiliation":[{"name":"Women and Kids, South Australian Health and Medical Research Institute; Adelaide Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2021,3,29]]},"reference":[{"issue":"Suppl 1","key":"10.1002\/14651858.CD001689.pub4-BIB0001|cit1","first-page":"S197","article-title":"Thromboembolism prophylaxis after cesarean section (PRO-CS) trial","volume":"130","author":"Algahtani","year":"2012","journal-title":"Thrombosis Research"},{"key":"10.1002\/14651858.CD001689.pub4-BIB0002|cit2","first-page":"749","article-title":"Thromboembolism prophylaxis after cesarean section (pro-cs) trial","volume":"98","author":"Algahtani","year":"2013","journal-title":"Haematologica"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD001689.pub4-BIB0003|cit3","first-page":"S71","article-title":"Thromboembolism prophylaxis after cesarean section (PRO-CS) trial","volume":"135","author":"Algahtani","year":"2015","journal-title":"Thrombosis Research"},{"key":"10.1002\/14651858.CD001689.pub4-BIB0004|cit4","unstructured":"Venous Thromboembolism Prophylaxis Post Cesarean Section (PROCS) https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01321788"},{"key":"10.1002\/14651858.CD001689.pub4-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/S0306-5456(00)00198-4","article-title":"A randomised, double blind placebo controlled trial of low molecular weight heparin as prophylaxis in preventing venous thromboembolic events after caesarean section: a pilot study","volume":"108","author":"Burrows","year":"2001","journal-title":"British Journal of Obstetrics and Gynaecology"},{"issue":"6 Suppl","key":"10.1002\/14651858.CD001689.pub4-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1016\/j.ajog.2005.10.036","article-title":"Bone density changes in women receiving thromboprophylaxis in pregnancy [abstract]","volume":"193","author":"Casele","year":"2005","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD001689.pub4-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.ajog.2006.06.080","article-title":"Bone density changes in women who receive thromboprophylaxis in pregnancy","volume":"195","author":"Casele","year":"2006","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD001689.pub4-BIB0008|cit8","unstructured":"Casele H Thrombosis prophylaxis in pregnancy www.enh.org"},{"key":"10.1002\/14651858.CD001689.pub4-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1177\/026835550201700206","article-title":"A randomised trial to compare the effect of pre- or postoperative nandroparin on blood loss during elective caesarean section","volume":"17","author":"Cornette","year":"2002","journal-title":"Phlebology"},{"key":"10.1002\/14651858.CD001689.pub4-BIB0010|cit10","unstructured":"Cruz M Fern\u00e1ndez-Alonso A Garrigosa L Cano A Carretero P Vizcaino A Postcesarean thromboprophylaxis with two different regimens of bemiparin [Article ID 548327] Obstetrics and Gynecology International"},{"issue":"6","key":"10.1002\/14651858.CD001689.pub4-BIB0011|cit11","first-page":"S182","article-title":"Dalteparin versus unfractionated heparin for prophylactic anticoagulation during pregnancy [abstract]","volume":"185","author":"De Veciana","year":"2001","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"5","key":"10.1002\/14651858.CD001689.pub4-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1111\/1471-0528.13421","article-title":"Does low-molecular-weight heparin influence fetal growth or uterine and umbilical arterial doppler in women with a history of early-onset uteroplacental insufficiency and an inheritable thrombophilia? Secondary randomised controlled trial results","volume":"123","author":"Abheiden","year":"2016","journal-title":"BJOG: an international journal of obstetrics and gynaecology"},{"key":"10.1002\/14651858.CD001689.pub4-BIB0013|cit13","unstructured":"Low molecular weight heparin (Fragmin (R)) in pregnant women with a history of uteroplacental insufficiency and thrombophilia, a randomized trial (FRUIT-study) http:\/\/www.isrctn.com\/ISRCTN87325378"},{"key":"10.1002\/14651858.CD001689.pub4-BIB0014|cit14","unstructured":"Low molecular weight heparin (Fragmin (R)) in pregnant women with a history of uteroplacental insufficiency and thrombophilia, a randomized trial (FRUIT-study) Https:\/\/www.trialregister.nl\/trial\/299"},{"issue":"3 Suppl 1","key":"10.1002\/14651858.CD001689.pub4-BIB0015|cit15","first-page":"69A","article-title":"Fractionated heparin in pregnant women with a history of uteroplacental insufficiency and thrombophilia, a randomized trial (The FRUIT Study)","volume":"18","author":"Vries","year":"2011","journal-title":"Reproductive Sciences"},{"issue":"6","key":"10.1002\/14651858.CD001689.pub4-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1111\/j.1538-7836.2012.04706.x","article-title":"Low-molecular-weight heparin added to aspirin in the prevention of recurrent early-onset pre-eclampsia in women with inheritable thrombophilia: the FRUIT-RCT: a reply to a rebuttal","volume":"10","author":"Vries","year":"2012","journal-title":"Journal of Thrombosis & Haemostasis"},{"key":"10.1002\/14651858.CD001689.pub4-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/j.1538-7836.2011.04553.x","article-title":"Low-molecular-weight heparin added to aspirin in the prevention of recurrent early-onset pre-eclampsia in women with inheritable thrombophilia: the FRUIT-RCT","volume":"10","author":"Vries","year":"2012","journal-title":"Journal of Thrombosis and Haemostasis"},{"key":"10.1002\/14651858.CD001689.pub4-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1055\/s-0037-1616738","article-title":"Thromboprophylaxis following caesarean section. A comparison of the antithrombotic properties of three low molecular weight heparins - dalteparin, enoxaparin and tinzaparin","volume":"86","author":"Ellison","year":"2001","journal-title":"Thrombosis and Haemostasis"},{"issue":"3","key":"10.1002\/14651858.CD001689.pub4-BIB0019|cit19","first-page":"94","article-title":"Comparisons of the anti-factor XA activities of three commonly used low molecular weight heparins following caesarean section","volume":"45","author":"Ellison","year":"2000","journal-title":"Scottish Medical Journal"},{"key":"10.1002\/14651858.CD001689.pub4-BIB0020|cit20","first-page":"823","article-title":"Thromboprophylaxis following caesarean section: comparison of the anti-factor Xa activities of dalteparin, enoxaparin and tinzaparin","volume":"107","author":"Ellison","year":"2000","journal-title":"British Journal of Obstetrics and Gynaecology"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD001689.pub4-BIB0021|cit21","first-page":"S39","article-title":"Thromboprophylaxis following caesarean section: comparison of the anti-factor Xa activities of three commonly used low molecular weight heparins","volume":"20","author":"Ellison","year":"2000","journal-title":"Journal of Obstetrics and Gynaecology"},{"issue":"Suppl 17","key":"10.1002\/14651858.CD001689.pub4-BIB0022|cit22","first-page":"53","article-title":"Thromboprophylaxis in pregnancy trials: apple, plum and peach","volume":"105","author":"Brocklehurst","year":"1998","journal-title":"British Journal of Obstetrics and Gynaecology"},{"key":"10.1002\/14651858.CD001689.pub4-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1016\/j.ajog.2004.03.039","article-title":"Thromboprophylaxis and pregnancy: two randomized controlled pilot trials that used low molecular weight heparin","volume":"191","author":"Gates","year":"2004","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"2 Suppl","key":"10.1002\/14651858.CD001689.pub4-BIB0024|cit24","first-page":"S44","article-title":"Antenatal thromboprophylaxis using low molecular weight heparin (enoxaparin) for women at risk of thromboembolic disease: multicentre placebo controlled randomised trial (APPLE) and systematic review","volume":"22","author":"Gates","year":"2002","journal-title":"Journal of Obstetrics and Gynaecology"},{"key":"10.1002\/14651858.CD001689.pub4-BIB0025|cit25","unstructured":"National Perinatal Epidemiology Unit The APPLE Study www.npeu.ox.ac.uk\/trials\/apple.html"},{"issue":"2 Suppl","key":"10.1002\/14651858.CD001689.pub4-BIB0026|cit26","first-page":"S52","article-title":"Randomised controlled trial (PEACH) and meta-analysis of thromboprophylaxis using low-molecular weight heparin (enoxaparin) after caesarean section","volume":"22","author":"Brocklehurst","year":"2002","journal-title":"Journal of Obstetrics and Gynaecology"},{"issue":"Suppl 17","key":"10.1002\/14651858.CD001689.pub4-BIB0027|cit27","first-page":"53","article-title":"Thromboprophylaxis in pregnancy trials: apple, plum and peach","volume":"105","author":"Brocklehurst","year":"1998","journal-title":"British Journal of Obstetrics and Gynaecology"},{"key":"10.1002\/14651858.CD001689.pub4-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1016\/j.ajog.2004.03.039","article-title":"Thromboprophylaxis and pregnancy: two randomized controlled pilot trials that used low molecular weight heparin","volume":"191","author":"Gates","year":"2004","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD001689.pub4-BIB0029|cit29","unstructured":"National Perinatal Epidemiology Unit The PEACH Study www.npeu.ox.ac.uk\/trials\/peach.html"},{"key":"10.1002\/14651858.CD001689.pub4-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1111\/j.1471-0528.1998.tb10212.x","article-title":"Puerperal thromboprophylaxis: comparison of the anti-Xa activity of enoxaparin and unfractionated heparin","volume":"105","author":"Gibson","year":"1998","journal-title":"British Journal of Obstetrics and Gynaecology"},{"issue":"1 Pt 2","key":"10.1002\/14651858.CD001689.pub4-BIB0031|cit31","first-page":"S66","article-title":"Low molecular weight heparin is associated with less peripartum blood loss than unfractionated heparin [abstract]","volume":"178","author":"Hamersley","year":"1998","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD001689.pub4-BIB0032|cit32","first-page":"10","article-title":"Perioperative thrombosis prophylaxis at the time of caesarean section: results of a randomised prospective comparative study with 6% hydroxyethyl starch 0.62 and low dose heparin","volume":"195","author":"Heilman","year":"1991","journal-title":"Zeitschrift fur Geburtshilfe und Perinatologie"},{"key":"10.1002\/14651858.CD001689.pub4-BIB0033|cit33","first-page":"211","article-title":"The rheological changes after cesarean section: the influence of low molecular weight or unfractionated heparin on the rheological properties of blood","volume":"37","author":"Heilmann","year":"2007","journal-title":"Clinical Hemorheology and Microcirculation"},{"issue":"1","key":"10.1002\/14651858.CD001689.pub4-BIB0034|cit34","first-page":"148","article-title":"Compression stockings during pregnancy: essential or superfluous? A pilot study","volume":"4","author":"Heller","year":"2016","journal-title":"Journal of Vascular Surgery: Venous and Lymphatic Disorders"},{"key":"10.1002\/14651858.CD001689.pub4-BIB0035|cit35","unstructured":"Preventing the development of venous insufficiency in pregnant women through use of compression stockings: a randomized pilot study http:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT01793194"},{"key":"10.1002\/14651858.CD001689.pub4-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1136\/bmj.296.6635.1505-a","article-title":"Effect of low dose heparin on blood loss at caesarean section","volume":"296","author":"Hill","year":"1988","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD001689.pub4-BIB0037|cit37","unstructured":"Hill NC Hill JG Sargent JM Taylor CG Bush PV The effect of low dose heparin on blood loss at caesarean section 12th FIGO World Congress of Gynecology and Obstetrics; 1988 October 23-28; Brazil 1988"},{"key":"10.1002\/14651858.CD001689.pub4-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1111\/j.1471-0528.1983.tb06458.x","article-title":"The risks of antenatal subcutaneous heparin prophylaxis: a controlled trial","volume":"90","author":"Howell","year":"1983","journal-title":"British Journal of Obstetrics and Gynaecology"},{"key":"10.1002\/14651858.CD001689.pub4-BIB0039|cit39","first-page":"120","article-title":"Use of LMW heparin (Fragmin) for the prevention of thromboembolism in obstetrics","volume":"198","author":"Krauss","year":"1994","journal-title":"Zeitschrift fur Geburtshilfe und Perinatologie"},{"key":"10.1002\/14651858.CD001689.pub4-BIB0040|cit40","unstructured":"O'Riordan MN Horgan R Arya A Quinn S Gaolebale PA Sarkar RK Pharmokinetics of low molecular weight heparins in the postpartum period Irish Perinatal Society Annual Meetings; 2008 April 11-12; Cork, Ireland 2008 10"},{"key":"10.1002\/14651858.CD001689.pub4-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0049-3848(99)00110-3","article-title":"Thromboprophylaxis with low molecular weight heparin (dalteparin) in pregnancy","volume":"96","author":"Pettila","year":"1999","journal-title":"Thrombosis Research"},{"issue":"2","key":"10.1002\/14651858.CD001689.pub4-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1055\/s-0037-1612970","article-title":"Postpartum bone mineral density in women treated for thromboprophylaxis with unfractionated heparin or LMW heparin","volume":"87","author":"Pettila","year":"2002","journal-title":"Thrombosis and Haemostasis"},{"issue":"9","key":"10.1002\/14651858.CD001689.pub4-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1055\/s-0033-1359720","article-title":"The effects of intermittent pneumatic compression during cesarean delivery on fibrinolysis","volume":"31","author":"Reddick","year":"2014","journal-title":"American Journal of Perinatology"},{"issue":"1","key":"10.1002\/14651858.CD001689.pub4-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1160\/TH06-10-0574","article-title":"The effect of dalteparin on coagulation activation during pregnancy in women with thrombophilia. A randomized trial","volume":"98","author":"Abou-Nassar","year":"2007","journal-title":"Thrombosis and Haemostasis"},{"issue":"11 Pt 1","key":"10.1002\/14651858.CD001689.pub4-BIB0045|cit45","first-page":"262","article-title":"The effect of dalteparin on coagulation activation during pregnancy in women with thrombophilia: a randomised trial","volume":"108","author":"Abou-Nassar","year":"2006","journal-title":"Blood"},{"key":"10.1002\/14651858.CD001689.pub4-BIB0046|cit46","unstructured":"Thrombophilia in pregnancy prophylaxis study (TIPPS) http:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT00967382"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD001689.pub4-BIB0047|cit47","first-page":"78","article-title":"The Thrombophilia in Pregnancy Prophylaxis Study (TIPPS): a multi-national randomized trial of dalteparin vs. no dalteparin to prevent pregnancy complications in pregnant thrombophilic women","volume":"11","author":"Rodger","year":"2013","journal-title":"Journal of Thrombosis and Haemostasis"},{"key":"10.1002\/14651858.CD001689.pub4-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1016\/S0140-6736(14)60793-5","article-title":"Antepartum dalteparin versus no antepartum dalteparin for the prevention of pregnancy complications in pregnant women with thrombophilia (TIPPS): a multinational open-label randomised trial","volume":"384","author":"Rodger","year":"2014","journal-title":"Lancet"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD001689.pub4-BIB0049|cit49","first-page":"8","article-title":"Prophylactic low molecular weight heparin (LMWH) during pregnancy is not associated with a decrease in bone mineral density (BMD) [abstract]","volume":"25","author":"Rodger","year":"2006","journal-title":"Hypertension in Pregnancy"},{"key":"10.1002\/14651858.CD001689.pub4-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1111\/j.1538-7836.2007.02634.x","article-title":"Long-term dalteparin in pregnancy not associated with a decrease in bone mineral density: substudy of a randomized controlled trial","volume":"5","author":"Rodger","year":"2007","journal-title":"Journal of Thrombosis and Haemostasis"},{"issue":"11","key":"10.1002\/14651858.CD001689.pub4-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"Abstract No 548","DOI":"10.1182\/blood.V106.11.548.548","article-title":"Prophylactic low molecular weight heparin (LMWH) during pregnancy is not associated with a decrease in bone mineral density (BMD). The TIPPS (Thrombophilia in Pregnancy Prophylaxis Study) BMD substudy","volume":"106","author":"Rodger","year":"2005","journal-title":"Blood"},{"key":"10.1002\/14651858.CD001689.pub4-BIB0052|cit52","unstructured":"Rodgers M Thrombophilia in pregnancy prophylaxis study (TIPPS) Ottawa Health Research Institute (http:\/\/www.ohri.ca)"},{"key":"10.1002\/14651858.CD001689.pub4-BIB0053|cit53","unstructured":"PROSPER: Postpartum prophylaxis for PE randomized control trial pilot http:\/\/clinicaltrials.gov\/show\/NCT01274637"},{"issue":"1","key":"10.1002\/14651858.CD001689.pub4-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1160\/TH14-06-0485","article-title":"Low-molecular-weight heparin to prevent postpartum venous thromboembolism. A pilot randomised placebo-controlled trial","volume":"113","author":"Rodger","year":"2015","journal-title":"Thrombosis and Haemostasis"},{"key":"10.1002\/14651858.CD001689.pub4-BIB0055|cit55","unstructured":"PROSPER: Postpartum prophylaxis for PE randomized control trial pilot http:\/\/clinicaltrials.gov\/show\/NCT01274637"},{"key":"10.1002\/14651858.CD001689.pub4-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.thromres.2016.04.004","article-title":"Low molecular weight heparin to prevent postpartum venous thromboembolism. A pilot study to assess the feasibility of a randomized open-label trial","volume":"142","author":"Rodger","year":"2016","journal-title":"Thrombosis Research"},{"issue":"1 Suppl 1","key":"10.1002\/14651858.CD001689.pub4-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"S457","DOI":"10.1016\/j.ajog.2016.11.527","article-title":"Placental findings following adjusting enoxaparin dosage according to anti-fxa levels in thrombophilic women. A randomized controlled trial","volume":"216","author":"Garmi","year":"2017","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"1","key":"10.1002\/14651858.CD001689.pub4-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1055\/s-0038-1676521","article-title":"Placental pathological findings following adjusting enoxaparin dosage in thrombophilic women: secondary analysis of a randomized controlled trial","volume":"119","author":"Garmi","year":"2019","journal-title":"Thrombosis and Haemostasis"},{"key":"10.1002\/14651858.CD001689.pub4-BIB0059|cit59","unstructured":"Dose adjusting enoxaparin thromboprophylaxis dosage according to anti-factor Xa plasma levels improve pregnancy outcome http:\/\/clinicaltrials.gov\/show\/NCT01068795"},{"issue":"4","key":"10.1002\/14651858.CD001689.pub4-BIB0060|cit60","first-page":"687","article-title":"Adjusting enoxaparin dosage according to anti-FXa levels and pregnancy outcome in thrombophilic women. A randomised controlled trial","volume":"116","author":"Salim","year":"2016","journal-title":"Thrombosis and Haemostasis"},{"key":"10.1002\/14651858.CD001689.pub4-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/0028-2243(75)90036-2","article-title":"Prevention of postpartum venous thrombosis with low doses of heparin","volume":"5","author":"Segal","year":"1975","journal-title":"European Journal of Obstetrics and Gynecology and Reproductive Biology"},{"key":"10.1002\/14651858.CD001689.pub4-BIB0062|cit62","unstructured":"Comparing anti-XA levels in post-cesarean patients undergoing enoxaparin thromboprophylaxis https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02070237"},{"issue":"1 Suppl 1","key":"10.1002\/14651858.CD001689.pub4-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1016\/j.ajog.2014.10.072","article-title":"Comparing anti-Xa levels in women with body mass index >\/=35 post cesarean delivery undergoing enoxaparin thromboprophylaxis with weight-based dosing twice daily versus fixed dose 40 mg daily: a randomized, controlled trial","volume":"212","author":"Stephenson","year":"2015","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"2","key":"10.1002\/14651858.CD001689.pub4-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/jp.2015.130","article-title":"A randomized controlled trial of differing doses of postcesarean enoxaparin thromboprophylaxis in obese women","volume":"36","author":"Stephenson","year":"2016","journal-title":"Journal of Perinatology"},{"key":"10.1002\/14651858.CD001689.pub4-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.ejogrb.2015.12.011","article-title":"Low-molecular-weight heparin and aspirin in the prevention of recurrent early-onset pre-eclampsia in women with antiphospholipid antibodies: the FRUIT-RCT","volume":"197","author":"Hoorn","year":"2016","journal-title":"European Journal of Obstetrics & Gynecology and Reproductive Biology"},{"issue":"11","key":"10.1002\/14651858.CD001689.pub4-BIB0066|cit66","first-page":"925","article-title":"Prevention of thromboembolism by physiotherapy with and without low dose heparin in gynecology and obstetrics. Results of a controlled, randomized multicenter study","volume":"101","author":"Welti","year":"1981","journal-title":"Revue Medicale de la Suisse Romande"},{"key":"10.1002\/14651858.CD001689.pub4-BIB0067|cit67","unstructured":"Aina A Study of patient compliance and comfort using sequential compression devices and foot pumps for DVT prevention https:\/\/clinicaltrials.gov\/ct2\/show\/results\/NCT00356434"},{"key":"10.1002\/14651858.CD001689.pub4-BIB0068|cit68","unstructured":"Alalaf A Bemiparin versus enoxaparin as thromboprophylaxis following vaginal and abdominal deliveries: a prospective clinical trial https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01588171"},{"key":"10.1002\/14651858.CD001689.pub4-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s12884-015-0515-2","article-title":"Bemiparin versus enoxaparin as thromboprophylaxis following vaginal and abdominal deliveries: a prospective clinical trial","volume":"15","author":"Alalaf","year":"2015","journal-title":"BMC Pregnancy & Childbirth"},{"issue":"3","key":"10.1002\/14651858.CD001689.pub4-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1080\/01443610802042688","article-title":"Low-molecular weight heparin in patients with recurrent early miscarriages of unknown aetiology","volume":"28","author":"Badawy","year":"2008","journal-title":"Journal of Obstetrics and Gynaecology"},{"key":"10.1002\/14651858.CD001689.pub4-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1097\/00001721-199806000-00006","article-title":"A pharmacokinetic study of dalteparin (Fragmin) during late pregnancy","volume":"9","author":"Blomback","year":"1998","journal-title":"Blood Coagulation and Fibrinolysis"},{"issue":"3","key":"10.1002\/14651858.CD001689.pub4-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.fertnstert.2005.03.048","article-title":"Effects of enoxaparin on late pregnancy complications and neonatal outcome in women with recurrent pregnancy loss and thrombophilia: results from the live-enox study","volume":"84","author":"Brenner","year":"2005","journal-title":"Fertility and Sterility"},{"issue":"11","key":"10.1002\/14651858.CD001689.pub4-BIB0073|cit73","first-page":"16a","article-title":"Enoxaparin treatment improves the gestational outcome of pregnant women with thrombophilia and recurrent pregnancy loss: the LIVE-ENOX study [abstract]","volume":"102","author":"Brenner","year":"2003","journal-title":"Blood"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD001689.pub4-BIB0074|cit74","first-page":"OC084","article-title":"Efficacy and safety of two doses of enoxaparin in pregnant women with thrombophilia and recurrent pregnancy loss: the LIVE-ENOX study [abstract]","volume":"1","author":"Brenner","year":"2003","journal-title":"Journal of Thrombosis and Haemostasis"},{"key":"10.1002\/14651858.CD001689.pub4-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/j.1538-7836.2004.01090.x","article-title":"Efficacy and safety of two doses of enoxaparin in women with thrombophilia and recurrent pregnancy loss: the LIVE-ENOX study","volume":"3","author":"Brenner","year":"2005","journal-title":"Journal of Thrombosis and Haemostasis"},{"issue":"11 Pt 1","key":"10.1002\/14651858.CD001689.pub4-BIB0076|cit76","first-page":"702a","article-title":"Efficacy and safety of two doses of enoxaparin in pregnant women with thrombophilia and recurrent pregnancy loss. The LIVE-ENOX study [abstract]","volume":"100","author":"Brenner","year":"2002","journal-title":"Blood"},{"issue":"1","key":"10.1002\/14651858.CD001689.pub4-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1186\/s13063-015-0719-9","article-title":"ALIFE2 study: low-molecular-weight heparin for women with recurrent miscarriage and inherited thrombophilia - study protocol for a randomized controlled trial","volume":"16","author":"Jong","year":"2015","journal-title":"Trials"},{"issue":"3","key":"10.1002\/14651858.CD001689.pub4-BIB0078|cit78","first-page":"143","article-title":"Safety and effectiveness of tinzaparin sodium in the management of recurrent pregnancy loss","volume":"34","author":"Dendrinos","year":"2007","journal-title":"Clinical and Experimental Obstetrics and Gynecology"},{"issue":"3","key":"10.1002\/14651858.CD001689.pub4-BIB0079|cit79","first-page":"408","article-title":"Antiphospholipid syndrome in pregnancy: a randomized, controlled trial of treatment","volume":"100","author":"Farquharson","year":"2002","journal-title":"Obstetrics and Gynecology"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD001689.pub4-BIB0080|cit80","first-page":"146","article-title":"Recurrent fetal loss: prospective evaluation of the efficacy of three different thromboprophylaxis regimens: aspirin versus low molecular weight heparin versus low molecular weight heparin plus aspirin [abstract]","volume":"91","author":"Chistolini","year":"2006","journal-title":"Hematology Journal"},{"issue":"7","key":"10.1002\/14651858.CD001689.pub4-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.3109\/14767058.2011.600366","article-title":"Efficacy of three different antithrombotic regimens on pregnancy outcome in pregnant women affected by recurrent pregnancy loss","volume":"25","author":"Giancotti","year":"2012","journal-title":"Journal of Maternal-Fetal and Neonatal Medicine"},{"issue":"4","key":"10.1002\/14651858.CD001689.pub4-BIB0082|cit82","first-page":"771","article-title":"Enoxaparin for the secondary prevention of placental vascular complications in women with abruptio placentae: the pilot randomised controlled NOH-AP trial","volume":"104","author":"Gris","year":"2010","journal-title":"Thrombosis and Haemostasis"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD001689.pub4-BIB0083|cit83","first-page":"753","article-title":"Enoxaparin for the secondary prevention of placental complications in women with previous severe pre-eclampsia: the pilot randomised controlled NOH-PE study","volume":"9","author":"Gris","year":"2011","journal-title":"Journal of Thrombosis and Haemostasis : JTH"},{"issue":"6","key":"10.1002\/14651858.CD001689.pub4-BIB0084|cit84","first-page":"1053","article-title":"Addition of enoxaparin to aspirin for the secondary prevention of placental vascular complications in women with severe pre-eclampsia: the pilot randomised controlled NOH-PE trial","volume":"106","author":"Gris","year":"2011","journal-title":"Thrombosis and Haemostasis"},{"key":"10.1002\/14651858.CD001689.pub4-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"930","DOI":"10.4236\/ojog.2014.415131","article-title":"Effectiveness of bemiparin sodium for preventing pregnancy loss in patients with MTHFR C677T mutation and habitual abortus","volume":"4","author":"Guven","year":"2014","journal-title":"Open Journal of Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD001689.pub4-BIB0086|cit86","first-page":"314","article-title":"Lack of anti-factor Xa activity in umbilical cord vein samples after subcutaneous administration of heparin or low molecular mass heparin in pregnant women","volume":"23","author":"Harenberg","year":"1993","journal-title":"Haemostasis"},{"issue":"17","key":"10.1002\/14651858.CD001689.pub4-BIB0087|cit87","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1056\/NEJMoa1000641","article-title":"Aspirin plus heparin or aspirin alone in women with recurrent miscarriage","volume":"362","author":"Kaandorp","year":"2010","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD001689.pub4-BIB0088|cit88","unstructured":"Middeldorp S Aspirin and\/or low molecular weight heparin for women with unexplained recurrent miscarriage and\/or intra-uterine fetal death Netherlands Trial Register (http:\/\/www.trialregister.nl)"},{"key":"10.1002\/14651858.CD001689.pub4-BIB0089|cit89","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.1055\/s-0028-1088777","article-title":"Therapy with dalteparin for habitual abortion - presentation of the ETHiG II-Studie","volume":"68","author":"Kamin","year":"2008","journal-title":"Geburtshilfe und Frauenheilkunde"},{"issue":"1","key":"10.1002\/14651858.CD001689.pub4-BIB0090|cit90","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1177\/1076029616658117","article-title":"Lessons from the EThIGII trial: Proper putative benefit assessment of low-molecular-weight heparin treatment in M2\/ANXA5 haplotype carriers","volume":"23","author":"Rogenhofer","year":"2017","journal-title":"Clinical and Applied Thrombosis\/Hemostasis"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD001689.pub4-BIB0091|cit91","first-page":"S220","article-title":"Low molecular weight heparin for the prevention of habitual abortion - introduction of the multicentre study EThIG2 and discussion of the current data","volume":"286","author":"Schleussner","year":"2012","journal-title":"Archives of Gynecology and Obstetrics"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD001689.pub4-BIB0092|cit92","doi-asserted-by":"crossref","first-page":"S73","DOI":"10.1016\/S0049-3848(13)70035-5","article-title":"Low-molecular-weight heparin in recurrent pregnancy loss-Results of the ETHIG II study","volume":"131","author":"Schleussner","year":"2013","journal-title":"Thrombosis Research"},{"key":"10.1002\/14651858.CD001689.pub4-BIB0093|cit93","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1111\/j.1600-0897.1996.tb00501.x","article-title":"A clinical trial for the treatment of antiphospholipid antibody-associated recurrent pregnancy loss with lower dose heparin and aspirin","volume":"35","author":"Kutteh","year":"1996","journal-title":"American Journal of Reproductive Immunology"},{"issue":"5","key":"10.1002\/14651858.CD001689.pub4-BIB0094|cit94","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1016\/S0002-9378(96)70610-5","article-title":"Antiphospholipid antibody-associated recurrent pregnancy loss: treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone","volume":"174","author":"Kutteh","year":"1996","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD001689.pub4-BIB0095|cit95","first-page":"WS_SL6_05","article-title":"Placental volume in women under treatment with recurrent miscarriages","volume":"34","author":"Langer","year":"2013","journal-title":"Ultraschall in der Medizin, Supplement"},{"key":"10.1002\/14651858.CD001689.pub4-BIB0096|cit96","unstructured":"Laskin CA A randomized controlled trial comparing low molecular weight heparin and aspirin to aspirin alone in women with unexplained recurrent pregnancy loss https:\/\/clinicaltrials.gov\/ct2\/show\/NCT00564174"},{"issue":"2","key":"10.1002\/14651858.CD001689.pub4-BIB0097|cit97","doi-asserted-by":"crossref","first-page":"279","DOI":"10.3899\/jrheum.080763","article-title":"Low molecular weight heparin and aspirin for recurrent pregnancy loss: results from the randomized, controlled HepASA Trial","volume":"36","author":"Laskin","year":"2009","journal-title":"Journal of Rheumatology"},{"issue":"10","key":"10.1002\/14651858.CD001689.pub4-BIB0098|cit98","first-page":"709","article-title":"Compression stockings in the prevention of venous disorders in pregnancy","volume":"33","author":"Milic","year":"2018","journal-title":"Phlebology"},{"issue":"3","key":"10.1002\/14651858.CD001689.pub4-BIB0099|cit99","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.fertnstert.2004.11.002","article-title":"Antiphospholipid antibodies associated with recurrent pregnancy loss: prospective, multicenter, controlled pilot study comparing treatment with low-molecular-weight heparin versus unfractionated heparin","volume":"83","author":"Noble","year":"2005","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD001689.pub4-BIB0100|cit100","first-page":"ii212","article-title":"Influence of enoxaparine on serum endotoxin concentration in puerpera after abdominal delivery","volume":"108","author":"Pyregov","year":"2012","journal-title":"British Journal of Anaesthesia"},{"key":"10.1002\/14651858.CD001689.pub4-BIB0101|cit101","first-page":"44","article-title":"Randomized trial of aspirin versus aspirin and heparin in pregnant women with the antiphospholipid syndrome","volume":"147 Suppl 1","author":"Cohen","year":"1996","journal-title":"Annales de Medicine Interne"},{"key":"10.1002\/14651858.CD001689.pub4-BIB0102|cit102","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1136\/bmj.314.7076.253","article-title":"Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies)","volume":"314","author":"Rai","year":"1997","journal-title":"BMJ"},{"issue":"3","key":"10.1002\/14651858.CD001689.pub4-BIB0103|cit103","first-page":"795","article-title":"Compression and walking compared with bed rest in the treatment of proximal deep venous thrombosis during pregnancy","volume":"113","author":"Ratiu","year":"2009","journal-title":"Revista Medico-Chirurgicala a Societatii de Medici Si Naturalisti Din Iasi"},{"issue":"1","key":"10.1002\/14651858.CD001689.pub4-BIB0104|cit104","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.1538-7836.2008.03230.x","article-title":"Dalteparin for the prevention of recurrence of placental-mediated complications of pregnancy in women without thrombophilia: a pilot randomized controlled trial","volume":"7","author":"Rey","year":"2009","journal-title":"Journal of Thrombosis and Haemostasis"},{"issue":"6 Suppl 1","key":"10.1002\/14651858.CD001689.pub4-BIB0105|cit105","first-page":"S46","article-title":"Dalteparin in prevention of recurrence of severe obstetrical complications in women without thrombophilia","volume":"29","author":"Rey","year":"2007","journal-title":"Journal of Obstetrics and Gynaecology Canada"},{"key":"10.1002\/14651858.CD001689.pub4-BIB0106|cit106","unstructured":"Rodger M A pilot study assessing the feasibility of a randomized controlled trial evaluating aspirin versus low-molecular-weight heparin (lmwh) and aspirin in women with antiphospholipid syndrome and pregnancy loss https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03100123"},{"key":"10.1002\/14651858.CD001689.pub4-BIB0107|cit107","first-page":"96","article-title":"Thromboprophylaxis with two different dosages of lmwh (calcic nadroparin) in pregnant women with thrombophilia: a single center experience","volume":"11","author":"Samantha","year":"2013","journal-title":"Journal of Thrombosis and Haemostasis"},{"issue":"9","key":"10.1002\/14651858.CD001689.pub4-BIB0108|cit108","doi-asserted-by":"crossref","first-page":"601","DOI":"10.7326\/M14-2062","article-title":"Low-molecular-weight heparin for women with unexplained recurrent pregnancy loss: a multicenter trial with a minimization randomization scheme","volume":"162","author":"Schleussner","year":"2015","journal-title":"Annals of Internal Medicine"},{"issue":"8","key":"10.1002\/14651858.CD001689.pub4-BIB0109|cit109","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/S1701-2163(16)30644-2","article-title":"Treatment of antiphospholipid antibody syndrome (aps) in pregnancy: a randomized pilot trial comparing low molecular weight heparin to unfractionated heparin","volume":"26","author":"Stephenson","year":"2004","journal-title":"Journal of Obstetrics and Gynaecology Canada"},{"issue":"6 Suppl 1","key":"10.1002\/14651858.CD001689.pub4-BIB0110|cit110","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1016\/j.ajog.2004.09.049","article-title":"Efficacy of enoxaparin for improving pregnancy outcomes and uteroplacental blood flow in women with thrombophilia and recurrent pregnancy loss [abstract]","volume":"191","author":"Thaler","year":"2004","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"7","key":"10.1002\/14651858.CD001689.pub4-BIB0111|cit111","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1093\/humrep\/12.7.1567","article-title":"Low-dose aspirin in prevention of miscarriage in women with unexplained or autoimmune related recurrent miscarriage: effect of prostacyclin and thromboxane A2 production","volume":"12","author":"Tulppala","year":"1997","journal-title":"Human Reproduction"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD001689.pub4-BIB0112|cit112","first-page":"S371","article-title":"A randomised controlled multicenter study: the effect of enoxaparin and\/or aspirin on prevention of recurrent miscarriage in women with or without thrombophilia, HABENOX-study","volume":"107","author":"Visser","year":"2009","journal-title":"International Journal of Gynecology and Obstetrics"},{"issue":"2","key":"10.1002\/14651858.CD001689.pub4-BIB0113|cit113","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1160\/TH10-05-0334","article-title":"Thromboprophylaxis for recurrent miscarriage in women with or without thrombophilia - HABENOX*: a randomised multicentre trial","volume":"105","author":"Visser","year":"2011","journal-title":"Thrombosis and Haemostasis"},{"issue":"4","key":"10.1002\/14651858.CD001689.pub4-BIB0114|cit114","first-page":"2172","article-title":"Comparison of efficacy and safety of two different enoxaparin products in prevention of venous thromboembolism following major obstetric-gynecological surgeries: an open-label randomized clinical trial","volume":"18","author":"Abdolvand","year":"2019","journal-title":"Iranian Journal of Pharmaceutical Research"},{"key":"10.1002\/14651858.CD001689.pub4-BIB0115|cit115","first-page":"A40","article-title":"Prevention of deep vein thrombosis (DVT) in pregnancy, after caesarean section and after gynaecological abdominal surgery. A comparison between low molecular weight heparin (LMW) and standard heparin (UFH) [abstract]","volume":"62 Suppl 1","author":"Dittmer","year":"1991","journal-title":"Annals of Haematology"},{"issue":"6","key":"10.1002\/14651858.CD001689.pub4-BIB0116|cit116","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1097\/AOG.0000000000003879","article-title":"Effect of digital step counter feedback on mobility after cesarean delivery: a randomized controlled trial","volume":"135","author":"Ganer Herman","year":"2020","journal-title":"Obstetrics and Gynecology"},{"issue":"1","key":"10.1002\/14651858.CD001689.pub4-BIB0117|cit117","doi-asserted-by":"crossref","first-page":"S397","DOI":"10.1016\/j.ajog.2019.11.639","article-title":"623: improving post-Cesarean mobility with personalized feedback using digital step counters - a randomized controlled trial","volume":"222","author":"Herman","year":"2020","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"3","key":"10.1002\/14651858.CD001689.pub4-BIB0118|cit118","doi-asserted-by":"crossref","first-page":"209","DOI":"10.34172\/jcvtr.2020.35","article-title":"Pregnancy outcome in women with mechanical prosthetic heart valves at their first trimester of pregnancy treated with unfractionated heparin (UFH) or enoxaparin: a randomized clinical trial","volume":"12","author":"Movahedi","year":"2020","journal-title":"Journal of Cardiovascular and Thoracic Research"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD001689.pub4-BIB0119|cit119","first-page":"S796","article-title":"The risk of venous thromboembolism and its prevention in obstetrics","volume":"119","author":"Nagornaya","year":"2012","journal-title":"International Journal of Gynecology and Obstetrics"},{"key":"10.1002\/14651858.CD001689.pub4-BIB0120|cit120","unstructured":"anti10a levels in women treated with LMWH in the postpartum period Https:\/\/clinicaltrials.gov\/show\/NCT02856295"},{"key":"10.1002\/14651858.CD001689.pub4-BIB0121|cit121","unstructured":"Impact of prophylactic low-molecular weight heparin dosing on clotting parameters following cesarean delivery Https:\/\/clinicaltrials.gov\/show\/NCT04305756"},{"key":"10.1002\/14651858.CD001689.pub4-BIB0122|cit122","unstructured":"Heparin Prophylaxis Dosing for antepartum hospitalizations (HEPDOSE) Https:\/\/clinicaltrials.gov\/show\/NCT04635839"},{"key":"10.1002\/14651858.CD001689.pub4-BIB0123|cit123","unstructured":"Dargaud Y Prospective multicentre randomized clinical trial on the management of pregnancies with high risk of venous thrombosis https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03659708"},{"issue":"2 Suppl","key":"10.1002\/14651858.CD001689.pub4-BIB0124|cit124","first-page":"42","article-title":"Compression stocking use in multiparous women during pregnancy & its effects on chronic venous insufficiency","volume":"31","author":"Heller","year":"2016","journal-title":"Phlebology"},{"key":"10.1002\/14651858.CD001689.pub4-BIB0125|cit125","unstructured":"The STOP CLOT pilot study: study of low molecular weight heparin in high risk postpartum women following cesarean section (ongoing trial) http:\/\/clinicaltrials.gov\/show\/NCT00225108"},{"key":"10.1002\/14651858.CD001689.pub4-BIB0126|cit126","unstructured":"Prophylactic enoxaparin dosing for prevention of venous thromboembolism in pregnancy http:\/\/clinicaltrials.gov\/ct2\/show\/record\/NCT00878826"},{"key":"10.1002\/14651858.CD001689.pub4-BIB0127|cit127","unstructured":"Heparin for pregnant with thrombophilia http:\/\/clinicaltrials.gov\/show\/NCT01019655"},{"key":"10.1002\/14651858.CD001689.pub4-BIB0128|cit128","first-page":"41","article-title":"Induced delivery and neuraxial anesthesia in pregnant women using thromboprophylaxis: data from the highlow study","volume":"1","author":"Bistervels","year":"2017","journal-title":"Research and Practice in Thrombosis and Haemostasis"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD001689.pub4-BIB0129|cit129","doi-asserted-by":"crossref","first-page":"S131","DOI":"10.1016\/S0049-3848(17)30169-X","article-title":"Neuraxial anesthesia in pregnant women using thrombosis prophylaxis: data from the Highlow study","volume":"Conference: 7th","author":"Bistervels","year":"2017","journal-title":"Thrombosis Research"},{"key":"10.1002\/14651858.CD001689.pub4-BIB0130|cit130","first-page":"866","article-title":"Management of anticoagulant therapy around delivery: results from the ongoing highlow study","volume":"3","author":"Bistervels","year":"2019","journal-title":"Research and Practice in Thrombosis and Haemostasis"},{"key":"10.1002\/14651858.CD001689.pub4-BIB0131|cit131","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.thromres.2016.06.001","article-title":"Low-molecular-weight heparin to prevent recurrent venous thromboembolism in pregnancy: Rationale and design of the Highlow study, a randomised trial of two doses","volume":"144","author":"Bleker","year":"2016","journal-title":"Thrombosis Research"},{"issue":"22","key":"10.1002\/14651858.CD001689.pub4-BIB0132|cit132","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1182\/blood.V128.22.1444.1444","article-title":"Interim report of the highlow study: a randomized controlled trial comparing two doses of low molecular weight heparin for the prevention of pregnancy-associated recurrent venous thromboembolism","volume":"128","author":"Bleker","year":"2016","journal-title":"Blood"},{"key":"10.1002\/14651858.CD001689.pub4-BIB0133|cit133","unstructured":"Highlow study: prevention of recurrent deep vein thrombosis and lung embolism in pregnant women Http:\/\/www.who.int\/trialsearch\/Trial2.aspx?TrialID=EUCTR2012-001505-24-ES"},{"key":"10.1002\/14651858.CD001689.pub4-BIB0134|cit134","unstructured":"Low-molecular-weight heparin to prevent recurrent VTE in pregnancy: a randomized controlled trial of two doses http:\/\/clinicaltrials.gov\/ct2\/show\/NCT01828697"},{"key":"10.1002\/14651858.CD001689.pub4-BIB0135|cit135","unstructured":"Pilot PARTUM Trial: Postpartum Aspirin to reduce thromboembolism undue morbidity (PARTUM) https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04153760"},{"issue":"2","key":"10.1002\/14651858.CD001689.pub4-BIB0136|cit136","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s00404-013-2923-8","article-title":"Trends, risk factors and mortality among women with venous thromboembolism during labour and delivery: a population based study of 8 million births","volume":"289","author":"Abbasi","year":"2014","journal-title":"Archives of Gynecology and Obstetrics"},{"key":"10.1002\/14651858.CD001689.pub4-BIB0137|cit137","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1097\/AOG.0000000000002706","article-title":"Thromboembolism in pregnancy. ACOG Practice Bulletin No. 196","volume":"132","author":"American College of Obstetricians and Gynecologists","year":"2018","journal-title":"Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD001689.pub4-BIB0138|cit138","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.thromres.2020.07.007","article-title":"Preventing postpartum venous thromboembolism: a call to action to reduce undue maternal morbidity and mortality","volume":"193","author":"Andrew","year":"2020","journal-title":"Thrombosis Research"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD001689.pub4-BIB0139|cit139","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00003495-200464001-00002","article-title":"Current options in the prevention of thromboembolic disease","volume":"64","author":"Ansell","year":"2004","journal-title":"Drugs"},{"key":"10.1002\/14651858.CD001689.pub4-BIB0140|cit140","volume-title":"Obstetrics: Normal and Problem Pregnancies","author":"Antony","year":"2017"},{"issue":"2 Suppl","key":"10.1002\/14651858.CD001689.pub4-BIB0141|cit141","first-page":"e691S\u2013e6736","article-title":"VTE, thrombophilia, antithrombotic therapy,and pregnancy: antithrombotic therapy and prevention of thrombosis, 9th ed:American College of Chest Physicians evidence-based clinical practice guidelines","volume":"141","author":"Bates","year":"2012","journal-title":"Chest"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD001689.pub4-BIB0142|cit142","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1016\/S0049-3848(09)70010-6","article-title":"Treatment of venous thromboembolism during pregnancy","volume":"123","author":"Bauersachs","year":"2009","journal-title":"Thrombosis Research"},{"key":"10.1002\/14651858.CD001689.pub4-BIB0143|cit143","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1160\/TH09-08-0559","article-title":"Venous thromboembolism during pregnancy, postpartum or during contraceptive use. RIETE Investigators","volume":"103","author":"Blanco-Molina","year":"2010","journal-title":"Thombosis and Haemostasis"},{"issue":"10","key":"10.1002\/14651858.CD001689.pub4-BIB0144|cit144","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1046\/j.1538-7836.2003.00504.x","article-title":"Antithrombotic prophylaxis for women with thrombophilia and pregnancy complications--Yes","volume":"1","author":"Brenner","year":"2003","journal-title":"Journal of Thrombosis and Haemostasis"},{"key":"10.1002\/14651858.CD001689.pub4-BIB0145|cit145","doi-asserted-by":"crossref","unstructured":"D'Souza R Malham\u00e9 I Teshler L Acharya G Hunt BJ McLintock C A critical review of the pathophysiology of thrombotic complications and clinical practice recommendations for thromboprophylaxis in pregnant patients with COVID-19 Acta Obstetricia et Gynecologica Scandinavica 2020 Jul 17 [Epub ahead of print] 10.1111\/aogs.13962","DOI":"10.1111\/aogs.13962"},{"issue":"7","key":"10.1002\/14651858.CD001689.pub4-BIB0146|cit146","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004734","article-title":"Aspirin and\/or heparin for women with unexplained recurrent miscarriage with or without inherited thrombophilia","author":"Jong","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"10063","key":"10.1002\/14651858.CD001689.pub4-BIB0147|cit147","doi-asserted-by":"crossref","first-page":"3060","DOI":"10.1016\/S0140-6736(16)30514-1","article-title":"Deep vein thrombosis and pulmonary embolism","volume":"388","author":"Di Nisio","year":"2017","journal-title":"Lancet"},{"issue":"7","key":"10.1002\/14651858.CD001689.pub4-BIB0148|cit148","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006780","article-title":"Antithrombotic therapy for improving maternal or infant health outcomes in women considered at risk of placental dysfunction","author":"Dodd","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD001689.pub4-BIB0149|cit149","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.thromres.2020.03.025","article-title":"Developing a model for predicting venous thromboembolism in obese pregnant women in a national study","volume":"191","author":"Ellis-Kahana","year":"2020","journal-title":"Thrombosis Research"},{"key":"10.1002\/14651858.CD001689.pub4-BIB0150|cit150","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1053\/j.semperi.2015.11.011","article-title":"Obstetrical venous thromboembolism: Epidemiology and strategies for prophylaxis","volume":"40","author":"Friedman","year":"2016","journal-title":"Seminars in Perinatology"},{"key":"10.1002\/14651858.CD001689.pub4-BIB0151|cit151","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1016\/S0140-6736(11)61904-1","article-title":"Pulmonary embolism and deep vein thrombosis","volume":"379","author":"Goldhaber","year":"2012","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD001689.pub4-BIB0152|cit152","first-page":"203","article-title":"Thrombosis in pregnancy: updates in diagnosis and management","volume":"2012","author":"Greer","year":"2012","journal-title":"Hematologic Diseases in Pregnancy"},{"key":"10.1002\/14651858.CD001689.pub4-BIB0153|cit153","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/0002-9343(80)90181-3","article-title":"Maternal and fetal sequelae of anticoagulation during pregnancy","volume":"68","author":"Hall","year":"1980","journal-title":"American Journal of Medicine"},{"issue":"5","key":"10.1002\/14651858.CD001689.pub4-BIB0154|cit154","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012852","article-title":"Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss","author":"Hamuly\u00e1k","year":"2020","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD001689.pub4-BIB0155|cit155","unstructured":"Higgins JPT Green S Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"issue":"233","key":"10.1002\/14651858.CD001689.pub4-BIB0156|cit156","first-page":"e1","article-title":"Incidence and risk patterns of venous thromboembolism in pregnancy and puerperium - a register-based case-control study","volume":"198","author":"Jacobsen","year":"2008","journal-title":"American Journal of Obstetrics andGynecology"},{"key":"10.1002\/14651858.CD001689.pub4-BIB0157|cit157","doi-asserted-by":"crossref","first-page":"1311\u20135","DOI":"10.1016\/j.ajog.2005.11.008","article-title":"Venous thromboembolism during pregnancy and the postpartum period: incidence, risk factors, and mortality","volume":"194","author":"James","year":"2006","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD001689.pub4-BIB0158|cit158","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/j.1471-0528.2007.01622.x","article-title":"Antenatal pulmonary emboism: risk factors, management and outcomes","volume":"115","author":"Knight","year":"2008","journal-title":"BJOG: an international journal of obstetrics and gynaecology"},{"key":"10.1002\/14651858.CD001689.pub4-BIB0159|cit159","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/S0950-3552(97)80026-0","article-title":"Peripartum prophylaxis of thromboembolism","volume":"11","author":"Letsky","year":"1997","journal-title":"Bailliere's Clinical Obstetrics and Gynaecology"},{"issue":"10","key":"10.1002\/14651858.CD001689.pub4-BIB0160|cit160","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1046\/j.1538-7836.2003.00503.x","article-title":"Antithrombotic prophylaxis for women with thrombophilia and pregnancy complications--No","volume":"1","author":"Middeldorp","year":"2003","journal-title":"Journal of Thrombosis and Haemostasis"},{"key":"10.1002\/14651858.CD001689.pub4-BIB0161|cit161","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S0950-3552(97)80024-7","article-title":"Hazards of heparin: allergy, heparin-induced thrombocytopenia and osteoporosis","volume":"11","author":"Nelson-Piercy","year":"1997","journal-title":"Bailliere's Clinical Obstetrics and Gynaecology"},{"key":"10.1002\/14651858.CD001689.pub4-BIB0162|cit162","volume-title":"Clinical Practice Guideline for the Prevention of Venous Thromboembolism (Deep Vein Thrombosis and Pulmonary Embolism) in Patients Admitted to Australian Hospitals","author":"National Health and Medical Research Council","year":"2009"},{"key":"10.1002\/14651858.CD001689.pub4-BIB0163|cit163","unstructured":"Venous thromboembolism in over 16s: reducing the risk of hospital-acquired deep vein thrombosis or pulmonary embolism (NG89) www.nice.org.uk\/guidance\/ng89 2018"},{"issue":"6","key":"10.1002\/14651858.CD001689.pub4-BIB0164|cit164","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1089\/jwh.2012.3600","article-title":"Prevention of venous thromboembolism in pregnancy: a review of guidelines, 2000\u20132011","volume":"21","author":"Okoroh","year":"2012","journal-title":"Journal of Women's Health"},{"issue":"6076","key":"10.1002\/14651858.CD001689.pub4-BIB0165|cit165","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1136\/bmj.1.6076.1564","article-title":"May mothers given warfarin breast-feed their infants?","volume":"1","author":"Orme","year":"1977","journal-title":"British Medical Journal"},{"issue":"13","key":"10.1002\/14651858.CD001689.pub4-BIB0166|cit166","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1111\/1471-0528.13706","article-title":"A comparison of recommendations for pharmacologic thromboembolism prophylaxis after caesarean delivery from three major guidelines","volume":"123","author":"Palmerola","year":"2016","journal-title":"BJOG: an international journal of obstetrics and gynaecology"},{"key":"10.1002\/14651858.CD001689.pub4-BIB0167|cit167","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1177\/0310057X8701500208","article-title":"A prospective study of dextran-induced anaphylactoid reactions in 5745 patients","volume":"15","author":"Paull","year":"1987","journal-title":"Anaesthesia and Intensive Care"},{"key":"10.1002\/14651858.CD001689.pub4-BIB0168|cit168","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/S0140-6736(00)02110-3","article-title":"Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin","volume":"355","author":"PEP Trial Collaborative Group","year":"2000","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD001689.pub4-BIB0169|cit169","unstructured":"The Royal College of Obstetricians and Gynaecologists Reducing the risk of thrombosis and embolism during pregnancy and puerperium. Green-top guideline https:\/\/www.rcog.org.uk\/en\/guidelines-research-services\/guidelines\/gtg37a\/ 2015 1 40"},{"key":"10.1002\/14651858.CD001689.pub4-BIB0170|cit170","unstructured":"Review Manager (RevMan) The Nordic Cochrane Center, The Cochrane Collaboration 2014"},{"key":"10.1002\/14651858.CD001689.pub4-BIB0171|cit171","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ajog.2016.09.076","article-title":"The role of aspirin dose on the prevention of preeclampsia and fetal growth restriction: systematic review and meta-analysis","volume":"February","author":"Roberge","year":"2017","journal-title":"American Journal of Obstetrics & Gynecology"},{"issue":"7","key":"10.1002\/14651858.CD001689.pub4-BIB0172|cit172","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1056\/NEJMoa1704559","article-title":"Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia","volume":"177","author":"Rolnik","year":"2017","journal-title":"New England Journal of Medicine"},{"issue":"1","key":"10.1002\/14651858.CD001689.pub4-BIB0173|cit173","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0306-5456(00)00004-8","article-title":"Venous thromboembolism in pregnancy and the puerperium: incidence and additional risk factors from a London perinatal database","volume":"108","author":"Simpson","year":"2001","journal-title":"British Journal of Obstetrics and Gynaecology"},{"issue":"2","key":"10.1002\/14651858.CD001689.pub4-BIB0174|cit174","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003580","article-title":"Heparin for pregnant women with acquired or inherited thrombophilias","author":"Walker","year":"2003","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD001689.pub4-BIB0175|cit175","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/j.1365-2141.2005.05715.x","article-title":"Screening for thrombophilia in high-risk situations: a meta-analysis and cost-effectiveness analysis","volume":"131","author":"Wu","year":"2005","journal-title":"British Journal of Haematology"},{"issue":"2","key":"10.1002\/14651858.CD001689.pub4-BIB0176|cit176","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001689.pub3","article-title":"Prophylaxis for venous thromboembolic disease in pregnancy and the early postnatal period","author":"Bain","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD001689.pub4-BIB0177|cit177","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001689","article-title":"Prophylaxis for venous thromboembolic disease in pregnancy and the early postnatal period","author":"Gates","year":"2002","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"5","key":"10.1002\/14651858.CD001689.pub4-BIB0178|cit178","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001689.pub2","article-title":"Prophylaxis for venous thromboembolic disease in pregnancy and the early postnatal period","author":"Tooher","year":"2010","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2024,7,23]],"date-time":"2024-07-23T05:11:17Z","timestamp":1721711477000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD001689.pub4"}},"subtitle":[],"editor":[{"name":"Cochrane Pregnancy and Childbirth Group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2021,3,29]]},"references-count":178,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2021,3]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd001689.pub4","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,29]]}}}